Q3 EPS Estimate for Neurocrine Biosciences Cut by Analyst
Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) – Equities researchers at Leerink Partnrs cut their Q3 2025 EPS estimates for shares of Neurocrine Biosciences in a report released on Monday, February 17th. Leerink Partnrs analyst M. Goodman now forecasts that the company will post earnings per share of $1.28 for the quarter, down from their […]
Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) – Equities researchers at Leerink Partnrs cut their Q3 2025 EPS estimates for shares of Neurocrine Biosciences in a report released on Monday, February 17th. Leerink Partnrs analyst M. Goodman now forecasts that the company will post earnings per share of $1.28 for the quarter, down from their […]
